Purchase Order EP11D000322

This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc. in the amount of $1,169,545.00 for the delivery of poliovirus vaccine. The contract has an ultimate completion date of May 21, 2015. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceuticals and medical supplies that has received numerous vaccine contracts from various federal agencies, including the Department of Veterans Affairs, Indian Health Service, Centers...

This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), to Pacific Immunology, a USA-based biotech company located in Ramona, California. The contract is for the production of monospecific antibodies, with a ceiling value of $4,321.60 and an ultimate completion date of March 10, 2010. The contract does not utilize a set-aside designation. Pacific Immunology, the prime...

This federal contract award is for a CUSTOMIZED POLYCLONAL ANTIBODY GENERATION SERVICE provided by Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $14,932.80, was awarded on August 21, 2015 by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract does not have a set-aside designation. Genscript has...

Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $132,000 firm fixed price purchase order to JPT Peptide Technologies GMBH. The contract calls for JPT to design, synthesize, purify, analyze, pool, and test overlapping peptides of the rabies envelope glycoprotein and HPV16 capsid L1 protein. These peptides will be used by NCI's Laboratory of Cellular Oncology to evaluate the potential of viral peptide libraries for cancer treatment. Key...

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $78,507.00 firm-fixed-price contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for Genscript Monoclonal Antibodies and Plasmid Services. This sole-source contract supports NIAID's Laboratory of Immunogenetics (LIG), which is expanding its work on isolating human monoclonal antibodies against COVID-19, malaria, and tuberculosis. The contract...

This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Eurofins Genomics LLC, a for-profit manufacturer of goods, to produce oligonucleotides for the CDC's Rapid Production of Oligonucleotides for Circulating Vaccine-Derived Poliovirus (OLIGO CVV RAPID PRODUCTION) program. The contract has a ceiling value of $171,193.00 and a period of performance ending on September 25, 2025. The contract does not have a set-aside designation. Eurofins...

The Defense Health Agency awarded a $84,720.53 firm fixed price purchase order to Genovac Antibody Discovery LLC, a small disadvantaged business, for the generation of monoclonal antibodies targeting ferret immunoglobulin M and immunoglobulin G. This requirement was solicited as a 100% small business set-aside. The contract has an ultimate completion date of December 29, 2023 and was awarded on May 1, 2023. The contract was issued under a federal contract opportunity posted on April 7, 2023 with...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $32,610 firm fixed price purchase order to JPT Peptide Technologies GmbH of Germany. The contract is to provide 20 units of a 158-peptide mixture and 25 units of a 102-peptide mixture related to the SARS-CoV-2 spike glycoprotein and nucleocapsid phosphoprotein, respectively, as referenced in the original solicitation. The peptides will support ongoing NIAID...